{"id":235683,"date":"2026-04-22T02:06:16","date_gmt":"2026-04-22T07:06:16","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/04\/mhealth-intervention-to-improve-hypertension-care-in-high-risk-patients"},"modified":"2026-04-22T02:06:16","modified_gmt":"2026-04-22T07:06:16","slug":"mhealth-intervention-to-improve-hypertension-care-in-high-risk-patients","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/04\/mhealth-intervention-to-improve-hypertension-care-in-high-risk-patients","title":{"rendered":"MHealth Intervention to Improve Hypertension Care in High-Risk Patients"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/mhealth-intervention-to-improve-hypertension-care-in-high-risk-patients2.jpg\"><\/a><\/p>\n<p>RESEARCH ARTICLE: mHealth Intervention to Improve Hypertension Care in High-Risk Patients <a href=\"https:\/\/twitter.com\/valnp\">@valnp<\/a> <a href=\"https:\/\/twitter.com\/countryside1991\">@countryside1991<\/a> <a href=\"https:\/\/twitter.com\/PDrawz\">@PDrawz<\/a><\/p>\n<hr>\n<p>BACKGROUND: The mGlide RCT (randomized controlled trial) evaluated whether a pharmacist-led, mobile health technology facilitated care model improves hypertension control in diverse populations. METHODS: We recruited adult English, Spanish, or Hmong-speaking patients with uncontrolled hypertension from a large health care system and smaller community clinics serving low-income patients. Participants were randomized 1:1 to mGlide or usual care. The 6-month intervention included daily blood pressure (BP) self-monitoring using a smartphone and wireless monitor, automated app-based data sharing, and responsive medication adjustment by a pharmacist-led provider-team. Comparison participants received a digital monitor. Outcomes included mean 6-month systolic BP (SBP), 12-month sustained BP control, 24-hour ambulatory BP and patient activation.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>RESEARCH ARTICLE: mHealth Intervention to Improve Hypertension Care in High-Risk Patients @valnp @countryside1991 @PDrawz BACKGROUND: The mGlide RCT (randomized controlled trial) evaluated whether a pharmacist-led, mobile health technology facilitated care model improves hypertension control in diverse populations. METHODS: We recruited adult English, Spanish, or Hmong-speaking patients with uncontrolled hypertension from a large health care system [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1495,1512],"tags":[],"class_list":["post-235683","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-health","category-mobile-phones"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/235683","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=235683"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/235683\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=235683"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=235683"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=235683"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}